Skip to content

A interventional study on knife-needle therapy based on the theory of myofascial trigger points for upper limb spastic paralysis after stroke

A interventional study on knife-needle therapy based on the theory of myofascial trigger points for upper limb spastic paralysis after stroke

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080315
Enrollment
Unknown
Registered
2024-01-25
Start date
2023-07-24
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral apoplexy

Interventions

Myofascia trigger points group:Knife-needle treatments
Ordinary acupuncture group:Acupuncture treatments

Sponsors

Hangzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria of Chinese and Western medicine and are diagnosed with cerebral infarction or cerebral hemorrhage by head CT or head MRI examination; (2) People aged 20-80 years old; (3) First onset, or previous history of stroke without sequelae; (4) The course of disease is less than 6 months; (5) Patients with clear consciousness, stable condition and high degree of cooperation; (6) The muscle tone of the paralyzed upper limb was evaluated by modified Ashworth scale (MAS), with muscle tone =I and =III; (7) Those who voluntarily participate in research, cooperate with examination and treatment, and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with acute stroke; (2) Patients who are delirious and unable to cooperate with examination and treatment after stroke; (3) Those who have received other treatment measures that may affect the efficacy indicators of this study, such as recent use of muscle relaxants; (4) Patients with serious life-threatening primary diseases such as cardiovascular and cerebrovascular, liver, kidney, hematopoietic system, and coagulation mechanism abnormalities, as well as neurological or mental diseases that cannot be treated; (5) Prior to stroke, there were shoulder and upper limb fractures, dislocation, acute and chronic soft tissue injuries, infectious inflammation, cervical spondylosis, rheumatoid arthritis, gout and other diseases causing upper limb pain and limited activity; (6) Certain characteristics of the population, such as pregnant women, breastfeeding, critically ill or terminally ill.

Design outcomes

Primary

MeasureTime frame
Modified Ashworth scale, MAS;

Secondary

MeasureTime frame
Fugl-Meyer assessment, FMA;Evaluation of curative effect;Amino acid neurotransmitter levels;

Countries

China

Contacts

Public ContactShen Linlin

Hangzhou Hospital of Traditional Chinese Medicine

434454364@qq.com+86 137 7758 1536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026